ReviewInternational urology and nephrology2024
Progress of SGLT2 inhibitors in the treatment of common immune-related nephropathies.
Guoqian Hu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewInternational urology and nephrology2024
Guoqian Hu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.